Doctor profile · Federal record
Dr. Jeffrey Geitz, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Salina, KS
- NPI 1124246855
- Accepts Medicare
- MIPS 77.5 / 100 · 2023
- 20 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
511 S Santa Fe Ave
Salina, KS 674014145
(785) 452-4860
fax (785) 452-4878
Credentials & registration
- NPI registered
- April 2007 — 19 yrs on file
- Profile last updated
- May 25, 2015
- Year of graduation
- 2006 — 20 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Kansas #04-32987
- Medicaid
- KS #200613380C
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1124246855. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
261,074
Distinct HCPCS
10
Medicare allowed
$4,198,754
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0641 |
Injection, levoleucovorin, not otherwise specified, 0.5 mg | 71,750 | 13 | $0 | |
J9299 |
Injection, nivolumab, 1 mg | 48,180 | 18 | $30 | |
Q5125 |
Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | 35,520 | 15 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 33,200 | 28 | $54 | |
Q5110 |
Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 30,420 | 16 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 11,880 | 19 | $23 | |
J9267 |
Injection, paclitaxel, 1 mg | 11,214 | 19 | $0 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 3,940 | 82 | $0 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,794 | 502 | $120 | |
J1437 |
Injection, ferric derisomaltose, 10 mg | 1,500 | 12 | $20 |
In context: peer comparison
Among 2 peers in Salina Hematology & Oncology Physician, average services per provider: 4,104. This provider delivers 64× the peer median.Open Payments
Industry payments received
All-time total
$1,208
Transactions
40
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $116.73 | |
| Pfizer INC. | 5 | $89.27 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $67.32 | |
| Merck Sharp & Dohme LLC | 3 | $64.61 | |
| Incyte Corporation | 3 | $54.34 | |
| Genentech USA, INC. | 3 | $45.70 | |
| Eisai INC. | 2 | $43.85 | |
| Gilead Sciences, INC. | 2 | $42.92 | |
| Janssen Biotech, INC. | 2 | $42.31 | |
| Lilly USA, LLC | 2 | $42.21 | |
| Takeda Pharmaceuticals U.S.A., INC. | 2 | $40.88 | |
| Exelixis INC. | 2 | $38.69 | |
| Pharmacosmos Therapeutics INC. | 2 | $33.95 | |
| Acrotech Biopharma INC. | 1 | $31.58 | |
| Sobi, INC | 1 | $27.47 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,387
Patients
271
Total drug cost
$1,131,021
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 359 | 69 | $9,403 |
| Anastrozole | Generic | 132 | 27 | $2,097 |
| Alendronate Sodium | Generic | 115 | 20 | $1,034 |
| Acyclovir | Generic | 112 | 20 | $1,785 |
| Prednisone | Generic | 76 | 22 | $530 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 76 | 15 | $351 |
| Tamoxifen Citrate | Generic | 72 | 16 | $1,609 |
| Dexamethasone | Generic | 69 | 20 | $846 |
| Eliquis (Apixaban) | Brand | 66 | 11 | $42,332 |
| Ibrance (Palbociclib) | Brand | 62 | 0 | $1,067,300 |
Hospital affiliations
Frequently asked questions
What is Dr. Jeffrey Geitz's medical specialty?
Dr. Jeffrey Geitz practices Hematology & Oncology Physician in Salina, KS.
Where does Dr. Jeffrey Geitz practice?
Dr. Jeffrey Geitz practices at 511 S Santa Fe Ave, Salina, KS 674014145. Office phone: 7854524860.
What is Dr. Jeffrey Geitz's NPI?
Dr. Jeffrey Geitz's National Provider Identifier (NPI) is 1124246855, issued by NPPES.
Does Dr. Jeffrey Geitz accept Medicare assignment?
Yes. Dr. Jeffrey Geitz accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jeffrey Geitz commonly perform?
Top Medicare-reported procedures in 2023: Injection, levoleucovorin, not otherwise specified, 0.5 mg (HCPCS J0641); Injection, nivolumab, 1 mg (HCPCS J9299); Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram (HCPCS Q5125). Source: CMS Medicare Physician & Other Practitioners file.